دورية أكاديمية
أعرض في EDS

Influence of depression on breast cancer treatment and survival: A Kentucky population-based study.

التفاصيل البيبلوغرافية
العنوان: Influence of depression on breast cancer treatment and survival: A Kentucky population-based study.
المؤلفون: Lei F; Department of Biostatistics, College of Public Health, University of Kentucky, Lexington, Kentucky, USA., Vanderpool RC; Division of Cancer Control and Population Sciences, Behavioral Research Program, Health Communication and Informatics Research Branch, National Cancer Institute, Bethesda, Maryland, USA., McLouth LE; Department of Behavioral Science, Center for Health Equity Transformation, College of Medicine, University of Kentucky, Lexington, Kentucky, USA., Romond EH; Department of Internal Medicine, College of Medicine, University of Kentucky, Lexington, Kentucky, USA., Chen Q; Kentucky Cancer Registry, Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.; Division of Cancer Biostatistics, Department of Internal Medicine, College of Medicine, University of Kentucky, Lexington, Kentucky, USA., Durbin EB; Kentucky Cancer Registry, Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.; Division of Biomedical Informatics, Department of Internal Medicine, College of Medicine, University of Kentucky, Lexington, Kentucky, USA., Tucker TC; Kentucky Cancer Registry, Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.; Department of Epidemiology and Environmental Health, College of Public Health, University of Kentucky, Lexington, Kentucky, USA., Tai E; Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Huang B; Kentucky Cancer Registry, Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA.; Division of Cancer Biostatistics, Department of Internal Medicine, College of Medicine, University of Kentucky, Lexington, Kentucky, USA.
المصدر: Cancer [Cancer] 2023 Jun 15; Vol. 129 (12), pp. 1821-1835. Date of Electronic Publication: 2023 Apr 17.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
أسماء مطبوعة: Publication: <2005- >: Hoboken, NJ : Wiley
Original Publication: New York [etc.] Published for the American Cancer Society by J. Wiley [etc.]
مواضيع طبية MeSH: Breast Neoplasms*/complications , Breast Neoplasms*/therapy , Breast Neoplasms*/diagnosis, Humans ; Female ; Kentucky/epidemiology ; Proportional Hazards Models ; Registries
مستخلص: Background: Depression is common among breast cancer patients and can affect concordance with guideline-recommended treatment plans. Yet, the impact of depression on cancer treatment and survival is understudied, particularly in relation to the timing of the depression diagnosis.
Methods: The Kentucky Cancer Registry data was used to identify female patients diagnosed with primary invasive breast cancer who were 20 years of age or older in 2007-2011. Patients were classified as having no depression, depression pre-cancer diagnosis only, depression post- cancer diagnosis only, or persistent depression. The impact of depression on receiving guideline-recommended treatment and survival was examined using multivariable logistic regression and Cox regression, respectively.
Results: Of 6054 eligible patients, 4.1%, 3.7%, and 6.2% patients had persistent depression, depression pre-diagnosis only, and depression post-diagnosis only, respectively. A total of 1770 (29.2%) patients did not receive guideline-recommended cancer treatment. Compared to patients with no depression, the odds of receiving guideline-recommended treatment were decreased in patients with depression pre-diagnosis only (odds ratio [OR], 0.75; 95% confidence interval [CI], 0.54-1.04) but not in patients with post-diagnosis only or persistent depression. Depression post-diagnosis only (hazard ratio, 1.51; 95% CI, 1.24-1.83) and depression pre-diagnosis only (hazard ratio, 1.26; 95% CI, 0.99-1.59) were associated with worse survival. No significant difference in survival was found between patients with persistent depression and patients with no depression (p > .05).
Conclusions: Neglecting depression management after a breast cancer diagnosis may result in poorer cancer treatment concordance and worse survival. Early detection and consistent management of depression is critical in improving patient survival.
(© 2023 American Cancer Society. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.)
References: J Clin Psychiatry. 2007;68 Suppl 2:36-41. (PMID: 17288506)
Psychooncology. 2010 Jun;19(6):637-45. (PMID: 19582800)
J Natl Cancer Inst. 2002 Apr 3;94(7):490-6. (PMID: 11929949)
J Rural Health. 2008 Fall;24(4):390-9. (PMID: 19007394)
Breast Cancer Res Treat. 2014 Jan;143(2):373-84. (PMID: 24337537)
Int J Cancer. 2003 Sep 1;106(3):416-22. (PMID: 12845683)
Eur J Cancer. 2005 Aug;41(12):1710-4. (PMID: 16098457)
Arch Intern Med. 2000 Jul 24;160(14):2101-7. (PMID: 10904452)
Soc Sci Med. 2021 Feb;270:113643. (PMID: 33387965)
Breast Cancer Res Treat. 2015 Nov;154(2):319-28. (PMID: 26518021)
J Oncol Pract. 2013 Jan;9(1):27-33. (PMID: 23633968)
J Clin Oncol. 2015 Oct 1;33(28):3177-85. (PMID: 26304878)
Psychooncology. 2011 Mar;20(3):252-9. (PMID: 20878837)
CA Cancer J Clin. 2016 Jul;66(4):271-89. (PMID: 27253694)
J Clin Oncol. 2017 Jan 20;35(3):334-342. (PMID: 28095267)
Chron Respir Dis. 2013 Feb;10(1):35-47. (PMID: 23355404)
J Am Geriatr Soc. 2004 Jan;52(1):106-11. (PMID: 14687323)
Psychooncology. 2016 Jan;25(1):19-27. (PMID: 26619290)
Breast Cancer Res Treat. 2007 Oct;105(2):209-19. (PMID: 17203386)
J Natl Compr Canc Netw. 2017 Jan;15(1):46-55. (PMID: 28040719)
J Clin Oncol. 2008 Oct 1;26(28):4666-71. (PMID: 18824713)
CA Cancer J Clin. 2020 Jan;70(1):7-30. (PMID: 31912902)
Cancer. 2017 Aug 15;123(16):3107-3115. (PMID: 28387934)
Ann Oncol. 2012 Jul;23(7):1756-65. (PMID: 22039090)
J Natl Compr Canc Netw. 2018 Mar;16(3):310-320. (PMID: 29523670)
Cancer. 2008 Feb 15;112(4):909-18. (PMID: 18189295)
Gen Hosp Psychiatry. 2008 Mar-Apr;30(2):112-26. (PMID: 18291293)
J Chronic Dis. 1987;40(5):373-83. (PMID: 3558716)
Gen Hosp Psychiatry. 2006 Sep-Oct;28(5):396-402. (PMID: 16950374)
Lancet. 2005 Dec 17;366(9503):2087-106. (PMID: 16360786)
World J Surg Oncol. 2004 Jan 22;2:2. (PMID: 14736343)
Breast Cancer Res Treat. 2015 Apr;150(2):395-403. (PMID: 25724306)
Gynecol Oncol. 2015 Jul;138(1):115-20. (PMID: 25922191)
J Clin Oncol. 2011 Feb 1;29(4):413-20. (PMID: 21149651)
Dig Dis Sci. 2017 Oct;62(10):2704-2712. (PMID: 28879547)
Depress Res Treat. 2012;2012:676784. (PMID: 22970357)
BMC Psychiatry. 2014 Oct 17;14:289. (PMID: 25322690)
J Clin Oncol. 2004 Oct 15;22(20):4184-92. (PMID: 15483029)
Annu Rev Clin Psychol. 2009;5:363-89. (PMID: 19327033)
Eur J Cancer. 2005 Mar;41(5):779-85. (PMID: 15763655)
Lancet. 2000 Oct 14;356(9238):1326-7. (PMID: 11073026)
JAMA. 2001 Feb 21;285(7):885-92. (PMID: 11180731)
Breast Cancer Res Treat. 2019 Feb;174(1):237-248. (PMID: 30465155)
Br J Cancer. 2009 Feb 10;100(3):545-50. (PMID: 19127253)
J Rural Health. 2017 Sep;33(4):375-381. (PMID: 27602545)
JAMA. 2003 Jun 18;289(23):3095-105. (PMID: 12813115)
Cancer. 2008 Dec 15;113(12):3450-8. (PMID: 19016270)
معلومات مُعتمدة: KL2 TR001996 United States TR NCATS NIH HHS; P30 CA177558 United States CA NCI NIH HHS
فهرسة مساهمة: Keywords: Appalachia; breast cancer; depression; guideline-recommended cancer treatment; survival
تواريخ الأحداث: Date Created: 20230417 Date Completed: 20230523 Latest Revision: 20240623
رمز التحديث: 20240623
مُعرف محوري في PubMed: PMC11106759
DOI: 10.1002/cncr.34676
PMID: 37063057
قاعدة البيانات: MEDLINE
الوصف
تدمد:1097-0142
DOI:10.1002/cncr.34676